Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexopoulos

Showing results (951-960 of 2,353) with videos related to

Pageof 236
Sort By:
Expert Review of Neurotherapeutics|December 3, 2009
Management of the patient with medically refractory epilepsyTiziana Granata, Nicola Marchi, Erin Carlton, et al.
European Urology|January 1, 1987
Idiopathic retroperitoneal fibrosis: a long-term follow-up studyE Alexopoulos, D Memmos, S Bakatselos, et al.
Psychological Medicine|July 15, 2015
Cognitive control, reward-related decision making and outcomes of late-life depression treated with an antidepressantG S Alexopoulos, K Manning, D Kanellopoulos, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 2, 2024
Racial Disparities in Evidence-Based Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 DiabetesAnastasia-Stefania Alexopoulos, Alice Parish, Maren Olsen, et al.
The American Journal of Psychiatry|July 1, 1985
Plasma 10-hydroxynortriptyline and ECG changes in elderly depressed patientsR C Young, G S Alexopoulos, C A Shamoian, et al.
Current Diabetes Reports|February 27, 2019
Triglycerides: Emerging Targets in Diabetes Care? Review of Moderate Hypertriglyceridemia in DiabetesAnastasia-Stefania Alexopoulos, Ali Qamar, Kathryn Hutchins, et al.
Transplantation|March 21, 2017
Improvement in the Outcomes of MELD ≥ 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSAVictor Nekrasov, Lea Matsuoka, Navpreet Kaur, et al.
Current Pharmaceutical Design|May 9, 2013
Factors affecting residual platelet aggregation in prasugrel treated patientsDimitrios Alexopoulos, Ioanna Xanthopoulou, Angelos Perperis, et al.
Plos Computational Biology|December 10, 2009
Identifying drug effects via pathway alterations using an integer linear programming optimization formulation on phosphoproteomic dataAlexander Mitsos, Ioannis N Melas, Paraskeuas Siminelakis, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2000
Structural comparison between type I and type II antagonists: possible implications in the drug design of AT1 antagonistsP Roumelioti, T Tselios, K Alexopoulos, et al.
Pageof 236

Showing results (951-960 of 2,353) with videos related to

Sort By:
Pageof 236
Expert Review of Neurotherapeutics|December 3, 2009
Management of the patient with medically refractory epilepsyTiziana Granata, Nicola Marchi, Erin Carlton, et al.
European Urology|January 1, 1987
Idiopathic retroperitoneal fibrosis: a long-term follow-up studyE Alexopoulos, D Memmos, S Bakatselos, et al.
Psychological Medicine|July 15, 2015
Cognitive control, reward-related decision making and outcomes of late-life depression treated with an antidepressantG S Alexopoulos, K Manning, D Kanellopoulos, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 2, 2024
Racial Disparities in Evidence-Based Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 DiabetesAnastasia-Stefania Alexopoulos, Alice Parish, Maren Olsen, et al.
The American Journal of Psychiatry|July 1, 1985
Plasma 10-hydroxynortriptyline and ECG changes in elderly depressed patientsR C Young, G S Alexopoulos, C A Shamoian, et al.
Current Diabetes Reports|February 27, 2019
Triglycerides: Emerging Targets in Diabetes Care? Review of Moderate Hypertriglyceridemia in DiabetesAnastasia-Stefania Alexopoulos, Ali Qamar, Kathryn Hutchins, et al.
Transplantation|March 21, 2017
Improvement in the Outcomes of MELD ≥ 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSAVictor Nekrasov, Lea Matsuoka, Navpreet Kaur, et al.
Current Pharmaceutical Design|May 9, 2013
Factors affecting residual platelet aggregation in prasugrel treated patientsDimitrios Alexopoulos, Ioanna Xanthopoulou, Angelos Perperis, et al.
Plos Computational Biology|December 10, 2009
Identifying drug effects via pathway alterations using an integer linear programming optimization formulation on phosphoproteomic dataAlexander Mitsos, Ioannis N Melas, Paraskeuas Siminelakis, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2000
Structural comparison between type I and type II antagonists: possible implications in the drug design of AT1 antagonistsP Roumelioti, T Tselios, K Alexopoulos, et al.
Pageof 236